NOX4 and idiopathic pulmonary fibrosis: Recently, several lines of evidence demonstrated that an expression of NOX4 was significantly elevated in IPF-derived human lung fibroblasts treated with TGF-β1 [26] and ASM in asthmatic patients [27].